- Home
- DXCM
DXCM
DexCom Inc.
as 01-17-2025 4:00pm EST
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 28.0B | IPO Year: | 2005 |
| Target Price: | $99.29 | AVG Volume (30 days): | 3.5M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.67 | EPS Growth: | 83.21 |
| 52 Week Low/High: | $62.34 - $142.00 | Next Earning Date: | 02-13-2025 |
| Revenue: | $3,954,000,000 | Revenue Growth: | 16.19% |
| Revenue Growth (this year): | 13.1% | Revenue Growth (next year): | 14.72% |
Stock Insider Trading Activity of DexCom Inc. (DXCM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Heller Bridgette P | DXCM | Director | Dec 16 '24 | Sell | $76.87 | 1,000 | $76,870.00 | 23,349 | |
| Sylvain Jereme M | DXCM | EVP, Chief Financal Officer | Dec 16 '24 | Sell | $76.87 | 744 | $57,191.28 | 80,030 | |
| Leach Jacob Steven | DXCM | EVP, Chief Operating Officer | Dec 16 '24 | Sell | $76.87 | 744 | $57,191.28 | 264,171 | |
| Stern Sadie | DXCM | EVP, Chief HR Officer | Dec 16 '24 | Sell | $76.87 | 424 | $32,592.88 | 70,768 | |
| Stern Sadie | DXCM | EVP, Chief HR Officer | Nov 20 '24 | Sell | $74.73 | 4,259 | $318,275.07 | 70,768 | |
| Sylvain Jereme M | DXCM | EVP, Chief Financal Officer | Nov 15 '24 | Sell | $75.51 | 3,500 | $264,285.00 | 80,030 |
Latest DexCom Inc. News
DXCM Breaking Stock News: Dive into DXCM Ticker-Specific Updates for Smart Investing
Morningstar Research
2 days ago
Analyst Report: DexCom, Inc.
Insider Monkey
2 days ago
Why DexCom, Inc. (DXCM) Is Skyrocketing
Investopedia
2 days ago
S&P 500 Gains and Losses Today: UnitedHealth Stock Ails as Results Fall Short
Investing.com
2 days ago
Baird raises DexCom stock to outperform, target to $104
MT Newswires
2 days ago
Baird Upgrades DexCom to Outperform From Neutral, Adjusts Price Target to $104 From $86
Motley Fool
2 days ago
2 Healthcare Stocks to Buy Hand Over Fist in January
MedTech Dive
3 days ago
Dexcom CEO talks Stelo sensor launch, OTC strategy
Argus Research
4 days ago
TRUP: Lowering target price to $46.00
Compare DXCM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DXCM DexCom Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.